LATTICE Radiotherapy (NCT07594431)

Name: LATTICE Radiotherapy trial for Metastases (NCT07594431)
Uploaded: 2026-10-31T17:21:17.517Z
Duration: 1 min 14 s
Description: LATTICE Radiotherapy trial for Metastases (NCT07594431). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07594431.

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.: a one-minute explainerNCT075944311 min

LATTICE Radiotherapy trial for Metastases (NCT07594431). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for people aged at least 12 with metastatic cancer and one or two tumors outside the brain, each over 2.5 centimeters on its short axis. Blood-cancer tumors and previously irradiated targets are excluded.

The idea: compare two five-session radiation treatments. Random assignment selects LATTICE radiation, with 20 gray and a simultaneous boost to 66.7 gray, or conventional radiation totaling 25 gray. Researchers measure tumor shrinkage after three months. It tests radiation-dose patterns.

This phase 2 study plans 80 patients. Stanford leads it in Palo Alto, the only recruiting US site.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.